Overview

ORIC-I: Optimizing Recovery From Intensive Care: Mechanical Ventilation and Delirium

Status:
Terminated
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if treating delirious intensive care unit patients with haloperidol improves mortality.
Phase:
Phase 3
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Haloperidol
Haloperidol decanoate